Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T62803 | STAT3-IN-12 | ||
STAT3-IN-12 是一种 STAT3 的有效信号抑制剂,对 IL-6 诱导的 JAK/STAT3 信号通路的激活具有抑制作用。STAT3-IN-12 对癌细胞生长、迁移具有抑制作用,可阻滞细胞周期并诱导细胞凋亡。STAT3-IN-12 能够用于癌症的相关研究(如肝细胞癌 (HCC) 、食管癌)。 | |||
T36645 |
CAY10763
CAY10763 |
||
CAY10763 is a dual inhibitor of indolamine 2,3-dioxygenase 1 (IDO1; IC50= 46 nM) and STAT3 activation.1It binds to STAT3 (Kd= 530 nM) and selectively reduces the levels of STAT3 phosphorylated at the tyrosine in position 705 (STAT3Y705) over phosphorylated STAT3S727, STAT1, and STAT5 in SKOV3 cells when used at a concentration of 500 nM. It also inhibits STAT3 nuclear translocation in SKOV3 cells. CAY10763 is cytotoxic to HCT116, SKOV3, A549, and HepG2 cancer cells (IC50s = 37, 28, 33, and 12 nM... | |||
T68306 |
INCB16562
|
||
INCB16562 is a novel, selective, and orally bioavailable small-molecule inhibitor of JAK1 and JAK2 markedly selective over JAK3. Treatment of myeloma cells with INCB16562 potently inhibited interleukin-6 (IL-6)-induced phosphorylation of STAT3. INCB16562 abrogated the protective effects of recombinant cytokines or bone marrow stromal cells and sensitized myeloma cells to cell death by exposure to dexamethasone, melphalan, or bortezomib. Oral administration of INCB16562 antagonized the growth of ... |